Innovative Health Initiative
Script error: No such module "AfC submission catcheck".
The Innovative Health Initiative (IHI) [1] is a public-private partnership between the European Union and the European life science industries. The partners of IHI are the European Union, represented by the European Commission, and the industry associations COCIR, EFPIA, Vaccines Europe, EuropaBio and MedTech Europe. Launched in January 2022, IHI is the successor to the Innovative Medicines Initiative.
IHI funds health research, with self-selecting consortia consisting of industry partners, universities, small and medium-sized enterprises (SMEs), patients, regulators and others working on projects related to disease prevention, diagnostics, treatments, and disease management.
References[edit]
Official website </ref> http://www.ihi.europa.eu/ </ref> IMI website [1] Public consultation on the creation of a new EU health partnership [2] European Council press release on the commitment to create IHI [3] Nine new EU partnerships created [4]
External links[edit]
- {{
This article "Innovative Health Initiative" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Innovative Health Initiative. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
- ↑ http://www.imi.europa.eu/
- ↑ http://www.ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/11906-European-Partnership-for-innovative-health-Horizon-Europe-programme-_en/
- ↑ http://www.consilium.europa.eu/en/press/press-releases/2021/11/19/council-commits-to-nine-institutionalised-european-partnerships/
- ↑ http://www.kowi.de/en/kowi/news/council-regulation-establishment-of-nine-joint-undertakings-institutionalised-european-partnerships.aspx
